SciELO - Scientific Electronic Library Online

 
vol.42 issue3Congenital cytomegalovirus infection in a neonatal intensive care unit in Brazil evaluated by PCR and association with perinatal aspectsSusceptibility of clinical isolates of Bacteroides fragilis group strains to cefoxitin, cefoperazone and ticarcillin/clavulanate author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista do Instituto de Medicina Tropical de São Paulo

Print version ISSN 0036-4665

Abstract

BELDA JUNIOR, Walter; SIQUEIRA, Luis Fernando de Goes  and  FAGUNDES, Luiz Jorge. Thiamphenicol in the treatment of chancroid. A study of 1,128 cases. Rev. Inst. Med. trop. S. Paulo [online]. 2000, vol.42, n.3, pp. 133-135. ISSN 0036-4665.  http://dx.doi.org/10.1590/S0036-46652000000300004.

Thiamphenicol, an aminic derivate of hydrocarbilsulfonil propandiol, was used for the treatment of 1,171 chancroid bearing patients. Each patient was medicated with 5.0 g of granulated thiamphenicol, orally, in a single dose, and was reevaluated 3, 7 and 10 days after the treatment. Ten patients (0.89%) did not respond to the proposed treatment. 133 patients presented healed ulcers after 3 days of treatment, 976 patients healed chancres on the seventh day after the treatment, and 39 patients took 10 days to present healed chancres. The results of this study indicate that the rate of patients that were cured, the low incidence of side effects, and the practicality of administration make of thiamphenicol an excellent choice for the treatment of chancroid.

Keywords : Thiamphenicol; Chancroid; Therapy.

        · abstract in Portuguese     · text in English     · pdf in English